A Dynamic Stopping Rule for Phase I Clinical Trials

Biometrical Letters
doi 10.2478/bile-2018-0002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

Futility Stopping in Clinical Trials

Statistics and its Interface
Applied MathematicsStatisticsProbability
2012English

A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2015English

Isotonic Design for Phase I Clinical Trials: Can We Improve Further?

Austrian Journal of Statistics
UncertaintyApplied MathematicsStatisticsProbability
2019English

Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2000English

Miscellanea. A Stopping Rule for the Continual Reassessment Method

Biometrika
StatisticsProbabilityUncertaintyApplied MathematicsBiological SciencesAgriculturalMathematics
1998English

A Simple Sequential Stopping Rule for Monte Carlo Simulation

IEEE Transactions on Communications
Electronic EngineeringElectrical
2006English

Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials

PLoS ONE
Multidisciplinary
2014English

Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials

Clinical Genitourinary Cancer
OncologyUrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy